|Awarded On||August 24, 2018|
|Title||Targeting Tumor Tissues Increases DNA Sensing to Bridge Innate and Adaptive Immunity|
|Award Mechanism||Multi-Investigator Research Awards (Version 2)|
|Institution/Organization||The University of Texas Southwestern Medical Center|
|Principal Investigator/Program Director||Zhijian J Chen|
|Cancer Sites||All Sites|
Cancer cells’ ability to develop resistance to conventional therapies poses one of the most daunting challenges to effective treatment. Strategic combinations of different therapies represent the future of cancer treatment, as they hold the greatest promise for overcoming therapeutic resistance. Radiation therapy’s primary aim is to kill cancer cells by damaging their DNA, but it has also been shown to stimulate the body’s immune system to attack cancer cells. For this reason, therapeutic combinations that pair radiation with immunotherapy, which also uses the immune system to fight cancer, are especially promising. The clinical usefulness of these combinations is currently limited, however,...